Affirmative Action with Leah Litman, Cost Implications with Dr. DeMartino, & Dr. John Mandrola

Here is a deep dive into cancer therapeutic costs, novel drug developments, and their effects on cost.

Can we afford it?

What about Long Covid?  More science, less speculation.  What causes the suffering, and ill effects, Is it vaccines?

An interview with constitutional law scholar Leah Litman, an Assistant Professor of Law at the University of Michigan, on Dr. Norman Wang and the intricacies of the laws on affirmative action. Next, we talk with Dr. Patrick DeMartino, a pediatric hematology/oncology fellow at Oregon Health & Science University, on his new paper out now in JAMA Internal Medicine: "Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018". Finally, we sit down with Dr. John Mandrola for an in-depth discussion on the intersection of medicine, politics, and advocate 

Soundcloud Podcast